Guidelines on the management of osteoporosis associated with chronic liver disease - PubMed (original) (raw)

Guideline

Guidelines on the management of osteoporosis associated with chronic liver disease

Jane D Collier et al. Gut. 2002 Feb.

No abstract available

PubMed Disclaimer

Figures

Figure 1

Summary of the strategy for prevention and treatment of osteoporosis in chronic liver disease. BMD, bone mineral density measured by dual energy x ray absorptiometry; HRT, hormone replacement therapy; SHBG, sex hormone binding globulin; FH, follicle stimulating hormone; LH, luteinising hormone.

Comment in

• Osteoporosis and liver disease: additional reasons for coeliac disease screening.
  Marignani M, Angeletti S, Morini S. Marignani M, et al. Gut. 2003 Mar;52(3):452. doi: 10.1136/gut.52.3.452. Gut. 2003. PMID: 12584234 Free PMC article. No abstract available.

References

1. 1. Calcif Tissue Int. 1997 Feb;60(2):148-54 - PubMed
2. 1. Gut. 1990 Jan;31(1):82-7 - PubMed
3. 1. J Bone Miner Res. 1997 Mar;12(3):472-8 - PubMed
4. 1. Gastroenterology. 1997 Jul;113(1):219-24 - PubMed
5. 1. J Clin Gastroenterol. 1997 Jun;24(4):239-44 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • HighWire
  • Ovid Technologies, Inc.
  • PubMed Central

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information